DrugPatentWatch Database Preview
Details for Patent: 8,877,708
» See Plans and Pricing
Which drugs does patent 8,877,708 protect, and when does it expire?
Patent 8,877,708 protects CYCLOSET and is included in one NDA.
This patent has ten patent family members in seven countries.
Summary for Patent: 8,877,708
| Title: | Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders |
| Abstract: | The present invention is directed to a method of treating a metabolic disorder or key elements of a metabolic disorder such method comprising the use of an agent(s) that increases central dopaminergic activity plus a first-phase insulin secretagouge. |
| Inventor(s): | Cincotta; Anthony H. (Tiverton, RI) |
| Assignee: | VeroScience, LLC (Tiverton, RI) |
| Application Number: | 13/375,810 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,877,708
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Y | TREATMENT OF TYPE 2 DIABETES BY ADMINISTERING BROMOCRIPTINE MESYLATE AND A FIRST-PHASE INSULIN SECRETAGOGUE WHEREIN THE COMBINED THERAPEUTIC EFFECT IS GREATER THAN THE ADDITIVE EFFECT OF ADMINISTERING EACH AGENT ALONE | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,877,708
| PCT Information | |||
| PCT Filed | June 07, 2010 | PCT Application Number: | PCT/US2010/037605 |
| PCT Publication Date: | December 09, 2010 | PCT Publication Number: | WO2010/141938 |
International Family Members for US Patent 8,877,708
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010256366 | Start Trial | |||
| Brazil | PI1009619 | Start Trial | |||
| China | 102458376 | Start Trial | |||
| European Patent Office | 2437732 | Start Trial | |||
| European Patent Office | 3375437 | Start Trial | |||
| Spain | 2682644 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
